--- title: "Tuoshan: Recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/251332691.md" description: "On the evening of August 3rd, Tuoshan announced that the cumulative deviation value of the closing price decline of its stock exceeded 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. The company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment" datetime: "2025-08-03T09:31:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/251332691.md) - [en](https://longbridge.com/en/news/251332691.md) - [zh-HK](https://longbridge.com/zh-HK/news/251332691.md) --- > 支持的语言: [English](https://longbridge.com/en/news/251332691.md) | [繁體中文](https://longbridge.com/zh-HK/news/251332691.md) # Tuoshan: Recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment On the evening of August 3rd, Tuoshan announced that the cumulative deviation value of the closing price decline of its stock exceeded 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. The company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment ### 相关股票 - [Tuoshan (001226.CN)](https://longbridge.com/zh-CN/quote/001226.CN.md) ## 相关资讯与研究 - [15:00 ET123Invent Inventor Develops Improved Design for an Envelope (PPA-336)](https://longbridge.com/zh-CN/news/278930124.md) - [Evergrande Property Services Updates Investors on Ongoing Takeover Talks](https://longbridge.com/zh-CN/news/278719332.md) - [Hyosung Heavy Industries wins 142.5 billion won order](https://longbridge.com/zh-CN/news/278698660.md) - [Ferretti board rejects takeover bid, urges shareholders to decline](https://longbridge.com/zh-CN/news/278994642.md) - [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/zh-CN/news/278372421.md)